XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Insider Trading Arrangements
 3 Months Ended 9 Months Ended
Sep. 30, 2023
shares
Sep. 30, 2023
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
During the three months ended September 30, 2023, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of BioMarin securities set forth in the table below.
Type of Trading Arrangement
NamePositionActionAdoption/Termination
Date		Rule 10b5-1*Non-
Rule 10b5-1**		Total Shares of Common Stock to be Sold***Expiration Date
Jean-Jacques BienaiméChairman and Chief Executive OfficerAdoptionAugust 7, 2023X
up to 191,000
June 3, 2024
G. Eric Davis
Executive Vice President, Chief Legal Officer and Secretary
AdoptionSeptember 13, 2023X
up to 164,429****
August 1, 2024
Henry J. Fuchs, M.D.President of Worldwide Research & DevelopmentAdoptionAugust 17, 2023X
up to 64,659
November 15, 2024
Brian R. MuellerExecutive Vice President and Chief Financial OfficerAdoptionAugust 23, 2023X
up to 12,495
July 30, 2024

*    Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
**     “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
***    Represents the maximum number of shares that may be sold pursuant to the 10b5-1 arrangement. The number of shares sold will be dependent on the satisfaction of certain conditions as set forth in the written plan.
**** Includes up to 41,680 shares subject to performance-based restricted stock units previously granted to Mr. Davis that may vest and be released to Mr. Davis on or before August 1, 2024 upon the satisfaction of the applicable vesting conditions. The actual number of shares that will be released to Mr. Davis pursuant to the performance-based restricted stock units and sold under the Rule 10b5-1 trading arrangement will be net of the number of shares withheld to satisfy tax withholding obligations arising from the vesting of such shares and is not yet determinable.
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Jean-Jacques Bienaimé [Member]    
Trading Arrangements, by Individual    
Name Jean-Jacques Bienaimé  
Title Chairman and Chief Executive Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 7, 2023  
Arrangement Duration 301 days  
Aggregate Available 191,000 191,000
G. Eric Davis [Member]    
Trading Arrangements, by Individual    
Name G. Eric Davis  
Title Executive Vice President, Chief Legal Officer and Secretary  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date September 13, 2023  
Arrangement Duration 323 days  
Aggregate Available 164,429 164,429
Henry J. Fuchs, M.D. [Member]    
Trading Arrangements, by Individual    
Name Henry J. Fuchs, M.D.  
Title President of Worldwide Research & Development  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 17, 2023  
Arrangement Duration 456 days  
Aggregate Available 64,659 64,659
Brian R. Mueller [Member]    
Trading Arrangements, by Individual    
Name Brian R. Mueller  
Title Executive Vice President and Chief Financial Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date August 23, 2023  
Arrangement Duration 342 days  
Aggregate Available 12,495 12,495